Emergent Biosolutions, Inc. short interest in 2026
In 2026, Emergent Biosolutions, Inc.'s disclosed short interest ran from 16.79% of shares outstanding on 15 Jan 2026 to 19.09% on 15 Sep 2026, a change of +2.30 percentage points. The year's high was 22.70% on 14 Aug 2026 and its low 16.42% on 30 Jan 2026, averaging 18.75% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.42 days on 30 Apr 2026. Full history: Emergent Biosolutions, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 16.79% (15 Jan 2026)
- End of year
- 19.09% (15 Sep 2026)
- Change
- +2.30 pp
- High
- 22.70% (14 Aug 2026)
- Low
- 16.42% (30 Jan 2026)
- Average
- 18.75%
- Highest days to cover
- 18.42 (30 Apr 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 16.79% | 8.41 | |
| 30 Jan 2026 | 16.42% | 9.83 | |
| 13 Feb 2026 | 16.89% | 13.66 | |
| 27 Feb 2026 | 17.11% | 7.67 | results (8-K), 10-K filed |
| 13 Mar 2026 | 16.90% | 7.37 | |
| 31 Mar 2026 | 18.38% | 11.29 | |
| 15 Apr 2026 | 18.36% | 13.53 | |
| 30 Apr 2026 | 18.95% | 18.42 | results (8-K) |
| 15 May 2026 | 18.61% | 11.99 | 10-Q filed |
| 29 May 2026 | 18.92% | 11.50 | |
| 15 Jun 2026 | 18.94% | 12.82 | |
| 30 Jun 2026 | 19.90% | 7.99 | |
| 15 Jul 2026 | 20.04% | 13.16 | |
| 31 Jul 2026 | 19.56% | 17.65 | |
| 14 Aug 2026 | 22.70% | 6.00 | results (8-K), 10-Q filed |
| 31 Aug 2026 | 21.15% | 9.15 | |
| 15 Sep 2026 | 19.09% | 8.60 |
See also: Emergent Biosolutions, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.